The medication is used for initial treatment of severe malaria. The drug is prescribed as in combination with an antimalarial agent that is active against the hypnozoite liver-stage forms of Plasmodium (eg, 8-aminoquinoline drug) to patients with severe malaria caused by P vivax or P ovale. Widely used as an intravenous drug, artesunate is prescribed to patients with uncomplicated malaria who are unable to take oral medications. The medication is available for sale in the form of tablets (at concentrations of 50mg, 100mg, 300mg), suppositories (at concentrations of 50mg, 100mg, and 200mg), solution for injection (at concentrations of 30mg, 60mg and 120mg ), vials (at concentration 60mg) as generic substance, also in combination with other drugs, like Amodiaquine, Sulfamethoxypyridazine, Pyrimethamine, Lumefantrine (at concentrations 25 mg, 100mg, 200 mg, 500 mg and more) from manufacturers in various countries including Y. The drug is provided by a wide range of artesunate suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading artesunate manufacturers and distributors are based in India and China.
How does Artesunate work?
DHA becomes active once artesunate is digested. In all erythrocytic phases, the Plasmodium parasites' ability to synthesise proteins and nucleic acids is inhibited by free radicals created when the endoperoxide bridge of DHA reacts with heme.
These medications are slow-acting antimalarials that would not start working for the treatment of severe malaria until far after 24 hours had passed. While waiting for IV artesunate, healthcare professionals will need to choose the most practical alternative for giving oral medications.
Licensing and brand names
Artesunate was first approved by the FDA on May 26, 2020, for the treatment of severe malaria. The medication is presently approved in many countries and is available in both generic and trade name versions. The drug is marketed under the trade names including Aarnet, Aarteto, Plasmotrim and many others. One of the more popular branded versions of artesunate is manufactured and supplied by the Chinese pharmaceutical companies JINLAN Pharm-Drugs Technology Co Ltd. Other manufacturing companies and distributors from European Union, Columbia, France and Italy, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with artesunate as an active ingredient.
The Cost of Artesunate
An online search for the wholesale price for sale of Artesunate for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The wholesale acquisition cost of medication in the U.S. is approximately 145 USD for 4 injections which contain 60mg of the substance in each injection. The retail price in the EU of this drug depending on the number of film-coated tablets in the pack ranges between 128 EUR and 448 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier.
Navigating our pharmaceutical marketplace
Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Artesunate distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Artesunate suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Artesunate. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Artesunate is already registered in. Manufacturers also have special, and delivery terms.
Establishing commercial ties
If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Artesunate suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Artesunate Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.